Cairns J A, Gordon J
Department of Immunology, Medical School, Birmingham, GB.
Eur J Immunol. 1990 Mar;20(3):539-43. doi: 10.1002/eji.1830200312.
When isolated from lysates of the RPMI 8866 B lymphoblastoid cell line, the CD23 antigen was found to be present be in two forms corresponding to the intact 45-kDa membrane species and to a 25-kDa product that is more usually found as a released fragment in the extracellular medium. By contrast with preparations of extracellular species of CD23 which were seen to be variable in their biological activity, cell-associated CD23 was consistently mitogenic both for autogenous transformed B lymphoblasts and for pre-activated normal B cells. Addition to the normal cocktail of protease inhibitors of N alpha-tosyl-L-lysine chloromethylketone (TLCK), which has selectivity for trypsin-like serine proteases, resulted in preparations of CD23 from RPMI 8866 cell lysates that were exclusively in the 45-kDa intact form; such material retained full and reliable activity in the biological assays. The implications of these observations for the autocrine control of B lymphocyte growth are discussed.
从RPMI 8866 B淋巴母细胞系的裂解物中分离时,发现CD23抗原以两种形式存在,分别对应完整的45 kDa膜蛋白和25 kDa产物,后者更常见于细胞外培养基中的释放片段。与细胞外CD23制剂的生物学活性可变不同,细胞相关的CD23对自身转化的B淋巴母细胞和预激活的正常B细胞均具有持续的促有丝分裂作用。向蛋白酶抑制剂的常规混合物中添加对胰蛋白酶样丝氨酸蛋白酶具有选择性的Nα-对甲苯磺酰-L-赖氨酸氯甲基酮(TLCK),可从RPMI 8866细胞裂解物中制备出仅为45 kDa完整形式的CD23;这种物质在生物学试验中保留了完全可靠的活性。讨论了这些观察结果对B淋巴细胞生长自分泌控制的意义。